Senior Scientist, In Vivo Cardiometabolic Diseases jobs in United States
cer-icon
Apply on Employer Site
company-logo

Merck · 10 hours ago

Senior Scientist, In Vivo Cardiometabolic Diseases

Merck is a leading company in the pharmaceutical industry, and they are seeking a highly innovative and rigorous Senior Scientist to lead research in cardiometabolic diseases. The successful candidate will manage complex research projects, develop in vivo animal models, and collaborate across teams to advance therapeutic targets for cardiovascular and renal disorders.

BiotechnologyHealth CareMedicalPharmaceutical
check
Comp. & Benefits
check
H1B Sponsorednote

Responsibilities

Independently initiate and lead discovery projects to uncover and validate therapeutic targets for cardio-renal diseases
Establish and characterize renal, cardiovascular, and metabolic animal models, utilizing functional in vivo endpoints, tissue/plasma genomics/proteomics/transcriptomics/metabolomics, and in vitro cell-based and biochemical assays
Develop and optimize in vitro systems and cell-based functional assays for mechanism-of-action studies and compound profiling and screening
Integrate omics data (including single-cell transcriptomics from patient-derived tissues) to inform target selection strategies
Leverage imaging strategies (e.g., confocal fluorescence microscopy or intravital multiphoton microscopy) to investigate quantitative disease endpoints
Spearhead collaborative projects across multidisciplinary teams and co-manage partnerships with external academic and industry collaborators
Present impactful findings at internal and external meetings and contribute to scientific publications and technical reports
Diligently document research activities using electronic lab notebooks; take on shared lab-based responsibilities

Qualification

Vivo Animal ModelsCardiovascular Disease BiologyMulti-Omics ApproachesData AnalysisVitro StudiesSurvival SurgeriesScientific CommunicationTeam CollaborationProblem SolvingMentoring

Required

Bachelor's (with 7 years), Master's (with 4 years) or Ph.D. (with 1 year) in Biology, Physiology or a related discipline and relevant experience in academic or industrial settings
Extensive hands-on experience in developing and characterizing in vivo rodent models for renal (e.g. DKD, ADPKD, FSGS) and cardiovascular disease (e.g. heart failure, ASCVD), including survival surgeries (e.g., osmotic mini-pump implantation), cardiovascular phenotyping (echocardiography, hemodynamic assessments), renal phenotyping (glomerular filtration rate measurements, assess serum and urinary biomarkers), and/or metabolic cage measurements
Experience in designing, executing, and interpreting in vitro and ex vivo experiments
Strong record of impactful publications, oral and poster presentations at international conferences, and recognition for research excellence
Proven ability to be a team player, lead collaborative cross-functional projects, and manage complex non-clinical studies
Advanced skills in scientific communication, data analysis (e.g. RStudio, GraphPad Prism, Ingenuity Pathway Analysis), statistical methods, and electronic lab documentation
Strategic and independent thinker with a drive to innovate and initiate, own and efficiently advance projects through the discovery pipeline. Proven ability to understand disease mechanisms and solve complex problems by undertaking innovative approaches and applying state-of-the art technologies

Preferred

Proficiency in iPSC-based assays and CRISPR/Cas9 gene editing
Demonstrated expertise in multi-omics approaches (single-cell RNA-seq, tissue/plasma proteomics) and data integration for target identification and validation

Benefits

Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days

Company

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Funding

Current Stage
Public Company
Total Funding
$5.59M
Key Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO

Leadership Team

leader-logo
Betty Larson
Executive Vice President and Chief Human Resources Officer
linkedin
leader-logo
Dean Li
Executive Vice President and President, Merck Research Laboratories
linkedin
Company data provided by crunchbase